Latest filing published 15 Aug 2016 for Valeant Pharmaceuticals International, Inc..
No signal scores available.
Argeris Karabelas is a declared insider of Valeant Pharmaceuticals International, Inc., with filings sourced from SEDI. Over a trading history stretching from 14 June 2016 to 11 August 2016, the count stands at 2 filings.
On the market, this insider has only ever bought: 1 purchase, €68k in total. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant.
On 15 August 2016 came the latest disclosure, a transaction in Valeant Pharmaceuticals International, Inc. The most recent open-market purchase was published on 15 August 2016, 3,723 days ago. Every figure here comes from the filings published by SEDI and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations